Zenas BioPharma, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zenas BioPharma, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $806.00K, a 53.19% decline year-over-year.
- Zenas BioPharma, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $367.00K, a 270.71% increase year-over-year.
- Zenas BioPharma, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $664.00K, a 1975.00% increase year-over-year.
- Zenas BioPharma, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.72M, a 1288.71% increase year-over-year.
- Zenas BioPharma, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $4.10M, a 1389.45% increase from fiscal 2024.
- Zenas BioPharma, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $275.00K, a 137.07% increase from fiscal 2023.
- Zenas BioPharma, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $116.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $806.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $367.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $4.10M 10-K · filed 2026-03-16 | |
| 2025-09-30 | $664.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.72M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $99.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $275.00K 10-K · filed 2026-03-16 | |
| 2024-09-30 | $32.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $124.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $42.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $116.00K 10-K · filed 2025-03-11 | |
| 2023-06-30 | $11.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $55.00K 10-Q · filed 2024-11-12 |